Firstly, the RANK insertion mutations associated with FEO, ESH and early-onset familial PDB are proposed to result in constitutive activation of NF-κB signalling in vitro (based on results from cell-based reporter assays) [8-10]. The gene discussed is TNFRSF11A; the disease is familial expansile osteolysis.